Cargando…
Exosome-Coated tPA/Catalase Nanoformulation for Thrombolytic Therapy
Current tissue plasminogen-based therapeutic strategies for stroke suffer from systemic side effects and poor efficacy. Hence, novel drug delivery methods are needed to overcome these shortcomings. Exosome-based drug formulations have been shown to have superior therapeutic outcomes compared to conv...
Autores principales: | Khalil, Sara, Kanapathipillai, Mathumai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9952084/ https://www.ncbi.nlm.nih.gov/pubmed/36829671 http://dx.doi.org/10.3390/bioengineering10020177 |
Ejemplares similares
-
Heparin and Arginine Based Plasmin Nanoformulation for Ischemic Stroke Therapy
por: Aamir, Ramsha, et al.
Publicado: (2021) -
Double-Gene Copromoting Expression Analysis in tPA/GH Transgenic Goat Mammary Epithelial Cells and Thrombolytic Activity of tPA In Vitro
por: Song, Shaozheng, et al.
Publicado: (2022) -
tPA or not tPA? Lysis therapy in the setting of COVID‐19 and ECMO
por: Cromartie, Anjelica, et al.
Publicado: (2022) -
Thrombolytic tPA-induced hemorrhagic transformation of ischemic stroke is mediated by PKCβ phosphorylation of occludin
por: Goncalves, Andreia, et al.
Publicado: (2022) -
Treating p53 Mutant Aggregation-Associated Cancer
por: Kanapathipillai, Mathumai
Publicado: (2018)